New Hope for Hand Osteoarthritis The drug talarozole – which increases retinoic acid – could be a promising new treatment for hand osteoarthritis. https://t.co/AHoEZM75mh https://t.co/dZ1LWWoNl5

Elevated Uric Acid Is Associated With New‐Onset Atrial Fibrillation A Longitudinal Swedish study has shown that elevated serum uric acid (SUA) levels has cardiovascular implications and may predict the development of atrial fibrillation (AFib). https://t.co/5PIOC4ymhB https://t.co/HRAe2tIerJ

UK BADBIR cohort study of 9057 PsA & PsO pts. A greater comorbidity burden and work inability seen PsA vs PsO cohort. PsA (HR 1.98), female sex & depression (HR 1.21) were associated with shorter persistence on ustekinumab. https://t.co/aBILQqXDKl https://t.co/tLNIhnxdXO

Join us! Take advantage of our early bird pricing. https://t.co/9Up0ZgaRP2 What attendees say about our meeting: 100% found the program free of commercial bias. 99% would recommend RheumNow Live to colleagues. 95% describe the content as extremely relevant to their practice. https://t.co/HOmh0CMyyJ

Causes of Enthesitis: SpA (AS, reactive arthritis, PsA, enteropathic arthritis, ERA), JIA, but also in RA, leprosy, trauma, OA, DISH, acromegaly, fluorosis, retinoid therapy, hypo- or hyper-PTH, POEMS syndrome, X-linked hypophosphatemia https://t.co/pff2OWBT5C https://t.co/7zm2la4GtD

Tofacitinib and RA-ILD Dr. Richard Conway discusses Abstract 2251 at ACR22 Convergence. Abstract 2251: Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib https://t.co/inndpqqbi8 https://t.co/8tRiKqT1x5

Ferritin may be more than biomarker in Stills, etc - may contribute directly to pathogenesis. Ferritin causes PMN activation & neutrophil extracellular traps (NETs). Could this be targeted therapeutically? https://t.co/yuvMaKqOa7 https://t.co/bjkEJvKH8d

Join RheumNow Live in person or virtually on 3/18 and 3/19. This meeting is unlike any other meeting you attended. But don't take our word for it, last year's attendees say: "Great conference. Best in the last year. I did Hopkins, CCR, and ACR too" https://t.co/jvhKcVXNtz https://t.co/Hc6SzsPKNa

PsA Til Death Do Us Part Dr. Jack Cush reviews the highlights from the past week on RheumNow https://t.co/8km1IGdmkZ https://t.co/Drxqq1QYsC

Hydroxychloroquine Dose and Risk for Incident Retinopathy A cohort study in Annals of Internal Medicine shows that higher hydroxychloroquine doses was associated with progressively greater risk for incident retinopathy. https://t.co/DZ2UxDKgUD https://t.co/tFtNZc1Eza

Poorer health outcomes for at-risk patients with fractures People at high risk of fracture are less likely to receive treatment for the underlying osteoporosis and also have poorer health outcomes. https://t.co/XmFcnBf6US https://t.co/mgAkb0NLBv

Rx failures w/ nonmedical switching of biosimilars may be Nocebo effect. 140 #RA pts, 51 non-switchers & 89 switchers. Non-switchers more likely to improve than switchers (68 vs 26%, p < 0.001) and less likely to worsen (1% vs 9%, p < 0.01). https://t.co/w8lnv1V5Pi https://t.co/iT2RkkSosl